Pia Lundman

5.1k total citations
70 papers, 2.5k citations indexed

About

Pia Lundman is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Pia Lundman has authored 70 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Surgery, 27 papers in Endocrinology, Diabetes and Metabolism and 26 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Pia Lundman's work include Lipoproteins and Cardiovascular Health (30 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers) and Health Systems, Economic Evaluations, Quality of Life (13 papers). Pia Lundman is often cited by papers focused on Lipoproteins and Cardiovascular Health (30 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers) and Health Systems, Economic Evaluations, Quality of Life (13 papers). Pia Lundman collaborates with scholars based in Sweden, Australia and United Kingdom. Pia Lundman's co-authors include Per Tornvall, Stephen J. Nicholls, Anders Hamsten, Philip J. Barter, Maria J. Eriksson, Björn W. Karlson, Michael K. Palmer, Ann Samnegård, Karin Schenck‐Gustafsson and Fredrik Karpe and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Scientific Reports.

In The Last Decade

Pia Lundman

65 papers receiving 2.4k citations

Peers

Countries citing papers authored by Pia Lundman

Since Specialization

Citations

This map shows the geographic impact of Pia Lundman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pia Lundman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pia Lundman more than expected).

Fields of papers citing papers by Pia Lundman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pia Lundman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pia Lundman. The network helps show where Pia Lundman may publish in the future.

Co-authorship network of co-authors of Pia Lundman

This figure shows the co-authorship network connecting the top 25 collaborators of Pia Lundman. A scholar is included among the top collaborators of Pia Lundman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pia Lundman. Pia Lundman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dysglycaemia and incident aortic stenosis: a cohort study 2025 ·Heart ·(unknown), Pia Lundman, Leif Friberg, Mats Talbäck, Niklas Hammar, Göran Walldius, Mozhu Ding, Anna Norhammar	2
2	Utilization and discontinuation of secondary prevention pharmacotherapy after myocardial infarction: a nationwide cohort study 2025 ·European Heart Journal - Cardiovascular Pharmacotherapy ·(unknown), (unknown), Emil Hagström, Pia Lundman, Jessica Schubert, Tomas Jernberg, Peter Ueda	0
3	Associations between inflammatory and angiogenic proteomic biomarkers, and cardiovascular events and mortality in relation to kidney function 2024 ·Clinical Kidney Journal ·(unknown), (unknown), Marie Evans, (unknown), Håkan Wallén, Tomas Jernberg, Thomas Kahan, Pia Lundman, Per Tornvall, David Erlinge, Bertil Lindahl, Tomasz Baron, Melinda Rezeli, Jonas Spaak, Stefan H. Jacobson	2
4	Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-aged individuals 2024 ·European Journal of Preventive Cardiology ·(unknown), Peter Ueda, Pia Lundman, Joakim Alfredsson, Annica Ravn‐Fischer, Stefan Söderberg, Troels Yndigegn, Emil Hagström, Tomas Jernberg	0
5	Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease 2024 ·Cardiovascular Diabetology ·Viveca Ritsinger, (unknown), Bo Lagerqvist, Pia Lundman, Anna Norhammar	0
6	Association between high-sensitivity C-reactive protein and coronary atherosclerosis in a general middle-aged population 2023 ·Scientific Reports ·(unknown), Pia Lundman, Joakim Alfredsson, Emil Hagström, Annica Ravn‐Fischer, Stefan Söderberg, Troels Yndigegn, Per Tornvall, Tomas Jernberg	16
7	Statin Treatment Intensity, Discontinuation, and Long-Term Outcome in Patients With Acute Myocardial Infarction and Impaired Kidney Function 2023 ·Journal of Cardiovascular Pharmacology ·(unknown), Karolina Szummer, Pia Lundman, Tomas Jernberg, Liyew Desta, Bertil Lindahl, David Erlinge, Stefan H. Jacobson, Jonas Spaak	0
8	Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trial 2023 ·Journal of Diabetes and its Complications ·Viveca Ritsinger, Emil Hagström, Kristina Hambræus, Stefan James, Tomas Jernberg, Bo Lagerqvist, Margrét Leósdóttir, Pia Lundman, John Pernow, Ollie Östlund, Anna Norhammar	3
9	Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney function 2022 ·International Journal of Cardiology ·(unknown), (unknown), (unknown), Robert Edfors, Stefan H. Jacobson, Håkan Wallén, Tomas Jernberg, Tomasz Baron, David Erlinge, Pontus Andell, Stefan James, Kai M. Eggers, Marcus Hjort, Thomas Kahan, Pia Lundman, Per Tornvall, Melinda Rezeli, György Marko‐Varga, Bertil Lindahl, Jonas Spaak	6
10	Arginase 1 is upregulated at admission in patients with ST‐elevation myocardial infarction 2021 ·Journal of Internal Medicine ·(unknown), (unknown), Dinos Verouhis, Felix Böhm, Per Eriksson, Lasse Folkersen, Anders Gabrielsen, Tomas Jernberg, Pia Lundman, Jonas Persson, Nawzad Saleh, Magnus Settergren, Peder Sörensson, Yahor Tratsiakovich, Per Tornvall, Christian Jung, John Pernow	9
11	Impaired fasting glucose: a risk factor for atrial fibrillation and heart failure 2021 ·Cardiovascular Diabetology ·(unknown), Niklas Hammar, Pia Lundman, Leif Friberg, Mats Talbäck, Göran Walldius, Anna Norhammar	20
12	Use of proteomics to identify biomarkers associated with chronic kidney disease and long‐term outcomes in patients with myocardial infarction 2020 ·Journal of Internal Medicine ·Robert Edfors, Lars Lindhagen, Jonas Spaak, Marie Evans, Pontus Andell, Tomasz Baron, (unknown), Melinda Rezeli, (unknown), Pia Lundman, Karolina Szummer, Per Tornvall, Håkan Wallén, Stefan H. Jacobson, Thomas Kahan, György Marko‐Varga, David Erlinge, Stefan James, Bertil Lindahl, Tomas Jernberg	8
13	Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study 2020 ·European Heart Journal ·(unknown), Tomas Jernberg, Emil Hagström, Margrét Leósdóttir, Pia Lundman, Peter Ueda	72
14	Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarction 2020 ·European Heart Journal - Cardiovascular Pharmacotherapy ·Marco Trevisan, Edouard L. Fu, Karolina Szummer, Anna Norhammar, Pia Lundman, Christoph Wanner, Arvid Sjölander, Tomas Jernberg, Juan Jesús Carrero	30
15	To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in each of the four statin benefit groups identified by the 2013 American College of Cardiology/American Heart Association guidelines? A VOYAGER meta-analysis 2015 ·Atherosclerosis ·Björn W. Karlson, Michael K. Palmer, Stephen J. Nicholls, Pia Lundman, Philip J. Barter	14
16	Achievement of 2011 European low-density lipoprotein cholesterol (LDL-C) goals of either <70 mg/dl or ≥50% reduction in high-risk patients: Results from VOYAGER 2013 ·Atherosclerosis ·Björn W. Karlson, Stephen J. Nicholls, Pia Lundman, Mike K. Palmer, Philip J. Barter	18
17	Comparison of the effects of different statins and doses on lipid levels in patients with diabetes: Results from VOYAGER 2012 ·Nutrition Metabolism and Cardiovascular Diseases ·B.W. Karlson, Philip J. Barter, M.K. Palmer, Pia Lundman, Stephen J. Nicholls	13
18	Association between statin treatment and outcome in relation to renal function in survivors of myocardial infarction 2011 ·Kidney International ·Karolina Szummer, Pia Lundman, Stefan H. Jacobson, Staffan Schön, Johan Lindbäck, Ulf Stenestrand, Lars Wallentin, Tomas Jernberg	22
19	Genetic and Environmental Influences on the Plasma Interleukin-6 Concentration in Patients with a Recent Myocardial Infarction: A Case–Control Study 2010 ·Journal of Interferon & Cytokine Research ·Marie Bennermo, Margareta Nordin, Pia Lundman, Sofia Boqvist, Claes Held, Ann Samnegård, Carl-Göran Ericsson, Angela Silveira, Anders Hamsten, (unknown), Per Tornvall	34
20	The Emerging Role of Lipoproteins in Atherogenesis: Beyond LDL Cholesterol 2004 ·Seminars in Vascular Medicine ·Stephen J. Nicholls, Pia Lundman	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact